Average Insider

Where insiders trade, we follow

ACADIA PHARMACEUTICALS INC ($ACAD)
Accession: 0001899977-26-000003
Mar 27, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$13.40
Current$21.4754.0% above low, 46.0% below high
52W High$28.35

Filing Information

Accession Number0001899977-26-000003
Form Type4
Filing DateMar 27, 2026
DocumentView SEC Filing
Transactions
7
Total Shares
36,017
Total Value
$159,135.88

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Common Stock
โ€”Mar 24, 2026Exercise/Conversion8,138โ€”โ€”61,476Directโ€”View Details
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Common Stock
โ€”Mar 25, 2026Sale4,177$21.47$89,680.1957,299Directโ€”View Details
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Common Stock
โ€”Mar 25, 2026Exercise/Conversion6,178โ€”โ€”63,477Directโ€”View Details
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Common Stock
โ€”Mar 26, 2026Sale3,171$21.65$68,652.1560,306Directโ€”View Details
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Common Stock
โ€”Mar 26, 2026Sale37$21.72$803.5460,269Directโ€”View Details
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Restricted Stock Units
(Common Stock)
DerivativeMar 24, 2026Exercise/Conversion8,138$0.00$0.0024,414Directโ€”View Details
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Restricted Stock Units
(Common Stock)
DerivativeMar 25, 2026Exercise/Conversion6,178$0.00$0.0012,358Directโ€”View Details
Version: v26.3.33